Startups Take On Illumina in Race for Cheaper DNA Sequencing

Higher Bills Are Leading Americans to Delay Medical Care

SOPHiA GENETICS Expands Partnership With AstraZeneca to Include Multimodal Approaches for Cancer Drug Development

Nectin Therapeutics, Merck Team Up on Immunotherapy Combo Trial in Solid Cancers

Sheba Medical Center Inaugurates World’s First ADAMS Center with MDClone Platform

Ibex Inks Deal With AstraZeneca, Daiichi Sankyo to Develop AI-Based HER2 Scoring

“אל תנהגו בפאניקה ותרוצו מיד לפיטורים וקיצוצים”: מה הופך מנהלים למנהלים טובים בזמן משבר?

New I-O Targets Herald a Decade of Drugging the Undruggable

Theranica partners with Dr Reddy’s for marketing wearable Nerivio in India

2022 Top 10 Innovations

“Global spend on healthcare is, by and large, recession-proof”

Nectin Therapeutics raises $25 million Series A to treat advanced cancer tumors

Meet the Israeli startups joining Google’s Growth Lab

משקיעות בביומד: הפרויקטים החדשים של TEAM8 ו-aMOON

Can Start-Ups Significantly Lower the Cost of Gene Sequencing?

From Post-it Notes to AI: How AI technology can improve workflow for mental health clinicians

המכונה הסודית של גלעד אלמוגי שמרצפת גנום ב-100 דולר לאדם

על קו הזינוק: נבחרת הסטארט-אפים 2022

Life sciences VC aMoon raises $340 million for second fund

“ה-AI זה כמו הענן בעבר: פעם כל חברה בתחום נחשבה פורצת דרך, היום לא נסתכל על חברה בלי יכולות בתחום”

Sophia Genetics, GE Healthcare Begin DEEP-Lung-IV Data Collection, Technology Integration

Andreessen, Founders Fund Back Genomics Startup Exiting Stealth

Welcome to ’tissue therapeutics’: Dave Lennon’s $110M new venture will implant ‘happy cells’ that ‘survive and thrive’

Eleos Health raises $20 million to generate insights from mental health clinician-patient conversations

Nectin Therapeutics Announces $5.4 Million Investment from Cancer Focus Fund to Support Phase 1 Study of First-in-Class Anti-PVR Targeted Immunotherapy

Warburg Pincus Co-Leads Latest Funding Round in Israel’s MDClone

Precision immunology player bags $110M to fund its work on ‘disease signature’ tests

Omada Health Valued at $1 Billion-Plus in Fidelity-Led Round

Investors expect to pour more funds into digital health, survey shows

12 על 12: הדמויות המשפיעות בענף ההלת’טק